Global engagement

Global engagement

Global engagement: Promoting innovative and inclusive approaches to research

An essential part of TDR’s work is to engage with the global health community to promote and facilitate the role of research for development and to advocate for the use of high-quality evidence to inform policy. TDR is at the interface between research and health care delivery and is embedded within the UN family through its cosponsors (UNICEF, UNDP, the World Bank, and WHO). This unique positioning allows TDR to create a bridge from local communities to the World Health Assembly to enable the broadest possible scope of dialogue and debate across the spectrum of health research – from priority setting to evidence-based policy-making at local, national, regional and global levels.

This global engagement includes promoting a broad range of community-based social innovations that are transforming health care delivery, shaping the research agenda, supporting the translation of evidence to policy, and leveraging a global network of more than 7000 scientists and experts who have been associated with TDR.
   

Recent news

Publications

Guidelines for laboratory and field testing of mosquito larvicides

Overview

 The purpose of this document is to provide specific and standardized procedures and guidelines for testing larvicides, including bacterial larvicides and insect growth regulators (IGRs), against mosquitoes. Its aim is to harmonize the testing procedures carried out in different laboratories and institutions to generate data for the registration and labelling of larvicides by national authorities.

The document is an expanded and updated version of the guidelines recommended by the WHO Pesticide Evaluation Scheme (WHOPES) Informal Consultation on the evaluation and testing of insecticides, held at WHO headquarters (HQ), Geneva, 7–11 October 1996. The guidelines were reviewed and recommended by the Eighth WHOPES Working Group Meeting, held at WHO-HQ, Geneva, 1–3 December 2004.

The document provides guidance on laboratory studies and small-scale and large-scale field trials to determine the efficacy, field application rates and operational feasibility and acceptability of a mosquito larvicide. The table below summarizes the sequence and objectives of the studies and trials. The procedures provide some information on the safety and toxicity of the larvicides for non-target organisms, but it is presumed that preliminary eco-toxicity and human assessments have been undertaken before any field study is carried out – detailed treatment and analysis of these extra data are beyond the scope of this document. 

WHO Team
Control of Neglected Tropical Diseases
Editors
Dr M. Zaim/Vector ecology and management
Number of pages
41
Reference numbers
WHO Reference Number: WHO/CDS/WHOPES/GCDPP/2005.13
Copyright
World Health Organization - Licence: CC BY-NC-SA 3.0 IGO.